Project Scientist: Neuroscientist / Cell Biologist - Glabe Lab
Open date: May 3, 2022
Next review date: Sunday, Apr 30, 2023 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.
Final date: Tuesday, May 2, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The Department of Molecular Biology and Biochemistry in the School of Biological Sciences is currently accepting applications in the area of the cellular, temporal and spatial dynamics of amyloid deposition and pathogenesis in transgenic models of Alzheimer’s disease. The person in the position will perform experiments with transgenic mice under the direction of Dr. Charles Glabe (https://www.faculty.uci.edu/Glabe). This NIH-funded project uses cell population-specific labeling of proteome to study the contributions of different populations of neurons and glia to amyloid deposition and the temporal and spatial mechanisms of plaque deposition and maturation. This person also will work on the contributions of glia to amyloid deposition. Renewal of the appointment will be contingent on the availability of adequate funding and performance.
Candidate demonstrates significant, original, and creative contribution to a research or creative program or project, demonstrates professional competency and activity, performing university and public service is encouraged.
The University of California, Irvine is ranked among the nation’s best research institutes with over $90,000,000 in current funding. Enrichment opportunities abound through the ADRC, the MIND Institute and the Center for the Neurobiology of Learning and Memory. Irvine has a pleasant climate and is five miles from the beach.
Ph.D. in neuroscience, cell biology, biochemistry or synthetic biology and an interest in Alzheimer’s disease. Super resolution fluorescence imaging and analysis and experience working with transgenic mice preferred. Experience in synthetic biology and proteomics is desirable. Candidate will be engaged in a program of advanced academic preparation and research training under the guidance of a faculty mentor/s, for a career typically outside the institution.
Qualified candidates should submit their curriculum vitae, a cover letter, and the names and contact information of three references to the following on-line recruitment URL:
Accepting all applicants.
Curriculum Vitae - Your most recently updated C.V.
Statement of Research (Optional)
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Misc / Additional (Optional)
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.